Fiona A. Schaeffer
Fiona Schaeffer has extensive experience in antitrust counseling, litigation, and transactional matters for clients in a broad range of industries, with particular depth of experience in the health care, financial services, and energy sectors. Fiona advises on antitrust aspects of mergers and acquisitions, structuring and operating joint ventures, distribution arrangements, licensing agreements, and other commercial transactions. She also defends clients in criminal and civil government investigations, and litigates in a variety of fora, including arbitration proceedings, consumer class actions, and private antitrust suits in federal and state courts. She has brought cases to the European General Court and Court of Justice in Luxembourg as well as litigated private actions in the U.K. Her extensive international experience brings added value to clients who conduct business globally and interact with different legal systems and regulators. After starting her career in Australia, Fiona practiced European competition law in London and Brussels for a number of years before moving to New York in 1998. She frequently represents clients in cross-border transactions and often serves as global coordinating antitrust counsel where transactions require merger approval in multiple jurisdictions. She is also active in Jones Day’s Latin America practice, with a particular focus on antitrust issues involving Brazil and Mexico. Fiona chairs the International Antitrust Committee of the ABA Antitrust Section and the Antitrust & Trade Reg. Committee of the New York City Bar and is a member of the Council of the ABA Section of International Law. She is repeatedly recognized in legal directories and was included among the Global Competition Review’s Top "40 under 40."
437 | Events
The U.S. Department of Justice and the New York State Attorney General have filed an antitrust lawsuit to dissolve a joint venture between two New York City tour bus companies that effectively merged their operations and eliminated competition between them. This enforcement action demonstrates (...)
On May 29, 2012, Brazil’s New Merger Law entered into force and the Administrative Council for Economic Defense ("CADE") issued Merger Regulations that further define what transactions must be reported and what filing procedures followed in Brazil’s new pre-merger control regime. On May 31, (...)
On December 1, 2011, Brazil’s new competition law was published in its final form, having been approved by President Dilma Rousseff. The new law goes into effect on May 29, 2012. Before approving the new law, President Rousseff vetoed several provisions that affect timing of review, settlement (...)
On October 5, 2011, Brazil’s Congress approved a new competition law that significantly restructures the landscape of competition enforcement in Brazil. Brazil’s Congress will now forward the bill to the desk of President Dilma Rousseff, who has 15 working days to approve or reject the bill. If (...)
Healthcare reform and concerns about consolidation in the health care industry juxtaposed with continuing economic distress provided a fascinating backdrop for the Federal Trade Commission’s (FTC’s) recent investigation of Scott & White Healthcare’s consummated acquisition of King’s (...)